BACKGROUND: We evaluated 10 single-nucleotide polymorphisms (SNPs) identified in three European case-control studies as risk factors for venous thrombosis. OBJECTIVES: We sought to replicate the positive findings from this report among Whites and to evaluate the association of these SNPs with venous thrombosis for the first time among Blacks. PATIENT/ METHODS: These SNPs were evaluated in a case-control study of deep vein thrombosis and pulmonary embolism that included 1076 cases and 1239 controls. About 50% of subjects were African Americans. We measured plasma factor (F) XI on a subset of subjects. RESULTS: Among Whites, positive findings for rs13146272 in the CYP4V2 gene, for rs3087505 in the KLKB1 gene and for rs3756008 and rs2036914 in the F11 gene were found. We did not find significant associations for rs2227589 in the SERPINC1 gene and for rs1613662 in the GP6 gene. Among Blacks, rs2036914 in F11 and rs670659 in RGS7 were related to venous thrombosis, but the study had limited statistical power for many SNPs. Among Blacks, plasma FXI was related to two SNPs and the OR relating to the 90th percentile of the control distribution of plasma FXI was 2.6 (95% CI, 1.4, 5.0). CONCLUSIONS: Our study supports the finding that genetic variants in the F11 gene are risk factors for venous thrombosis among both Whites and Blacks, although the findings in Blacks require confirmation. A meta-analysis of five case-control studies indicates that rs2227589 in the SERPINC1 gene, rs13146272 in the CYP4V2 gene and rs1613662 in the GP6 gene are risk factors for venous thrombosis among Whites.
BACKGROUND: We evaluated 10 single-nucleotide polymorphisms (SNPs) identified in three European case-control studies as risk factors for venous thrombosis. OBJECTIVES: We sought to replicate the positive findings from this report among Whites and to evaluate the association of these SNPs with venous thrombosis for the first time among Blacks. PATIENT/ METHODS: These SNPs were evaluated in a case-control study of deep vein thrombosis and pulmonary embolism that included 1076 cases and 1239 controls. About 50% of subjects were African Americans. We measured plasma factor (F) XI on a subset of subjects. RESULTS: Among Whites, positive findings for rs13146272 in the CYP4V2 gene, for rs3087505 in the KLKB1 gene and for rs3756008 and rs2036914 in the F11 gene were found. We did not find significant associations for rs2227589 in the SERPINC1 gene and for rs1613662 in the GP6 gene. Among Blacks, rs2036914 in F11 and rs670659 in RGS7 were related to venous thrombosis, but the study had limited statistical power for many SNPs. Among Blacks, plasma FXI was related to two SNPs and the OR relating to the 90th percentile of the control distribution of plasma FXI was 2.6 (95% CI, 1.4, 5.0). CONCLUSIONS: Our study supports the finding that genetic variants in the F11 gene are risk factors for venous thrombosis among both Whites and Blacks, although the findings in Blacks require confirmation. A meta-analysis of five case-control studies indicates that rs2227589 in the SERPINC1 gene, rs13146272 in the CYP4V2 gene and rs1613662 in the GP6 gene are risk factors for venous thrombosis among Whites.
Authors: Irene D Bezemer; Lance A Bare; Carine J M Doggen; Andre R Arellano; Carmen Tong; Charles M Rowland; Joseph Catanese; Bradford A Young; Pieter H Reitsma; James J Devlin; Frits R Rosendaal Journal: JAMA Date: 2008-03-19 Impact factor: 56.272
Authors: Y Li; I D Bezemer; C M Rowland; C H Tong; A R Arellano; J J Catanese; J J Devlin; P H Reitsma; L A Bare; F R Rosendaal Journal: J Thromb Haemost Date: 2009-07-06 Impact factor: 5.824
Authors: Marek Postula; Piotr K Janicki; Marek Rosiak; Agnieszka Kaplon-Cieslicka; Ewa Trzepla; Krzysztof J Filipiak; Dariusz A Kosior; Andrzej Czlonkowski; Grzegorz Opolski Journal: J Thromb Thrombolysis Date: 2013-07 Impact factor: 2.300
Authors: Eun-Ju Lee; Daniel J Dykas; Andrew D Leavitt; Rodney M Camire; Eduard Ebberink; Pablo García de Frutos; Kavitha Gnanasambandan; Sean X Gu; James A Huntington; Steven R Lentz; Koen Mertens; Christopher R Parish; Alireza R Rezaie; Peter P Sayeski; Caroline Cromwell; Noffar Bar; Stephanie Halene; Natalia Neparidze; Terri L Parker; Adrienne J Burns; Anne Dumont; Xiaopan Yao; Cassius Iyad Ochoa Chaar; Jean M Connors; Allen E Bale; Alfred Ian Lee Journal: Blood Adv Date: 2017-06-29
Authors: Kim Fechtel; Marika L Osterbur; Hildegard Kehrer-Sawatzki; Peter D Stenson; David N Cooper Journal: Hum Genet Date: 2011-05-03 Impact factor: 4.132
Authors: Bengt Sennblad; Saonli Basu; Johanna Mazur; Pierre Suchon; Angel Martinez-Perez; Astrid van Hylckama Vlieg; Vinh Truong; Yuhuang Li; Jesper R Gådin; Weihong Tang; Vera Grossman; Hugoline G de Haan; Niklas Handin; Angela Silveira; Juan Carlos Souto; Anders Franco-Cereceda; Pierre-Emmanuel Morange; France Gagnon; Jose Manuel Soria; Per Eriksson; Anders Hamsten; Lars Maegdefessel; Frits R Rosendaal; Philipp Wild; Aaron R Folsom; David-Alexandre Trégouët; Maria Sabater-Lleal Journal: Hum Mol Genet Date: 2017-02-01 Impact factor: 6.150
Authors: John A Heit; Sebastian M Armasu; Bryan M McCauley; Iftikhar J Kullo; Hugues Sicotte; Jyotishman Pathak; Christopher G Chute; Omri Gottesman; Erwin P Bottinger; Joshua C Denny; Dan M Roden; Rongling Li; Marylyn D Ritchie; Mariza de Andrade Journal: Thromb Haemost Date: 2017-02-16 Impact factor: 5.249
Authors: Aaron R Folsom; Weihong Tang; Nicholas S Roetker; Susan R Heckbert; Mary Cushman; James S Pankow Journal: Am J Hematol Date: 2015-11 Impact factor: 10.047
Authors: Christina L Wassel; Laura J Rasmussen-Torvik; Peter W Callas; Julie O Denenberg; J Peter Durda; Alexander P Reiner; Nicholas L Smith; Matthew A Allison; Frits R Rosendaal; Michael H Criqui; Mary Cushman Journal: Thromb Res Date: 2015-09-26 Impact factor: 3.944
Authors: Hanne Skille; Benedikte Paulsen; Kristian Hveem; Maiken E. Gabrielsen; Ben Brumpton; Kristian Hindberg; Olga V. Gran; Frits R. Rosendaal; Sigrid K. Brækkan; John-Bjarne Hansen Journal: Haematologica Date: 2019-11-07 Impact factor: 9.941